Mylan pushed the blame for high EpiPen prices onto PBMs Thursday, causing share prices to dip. Analysts say investors were mislead.
Yesterday, Express Scripts (ESRX) got beaten down after it and other pharmacy benefits managers like CVS Health (CVS) were blamed by Mylan (MYL) for the rise in EpiPen prices. Jefferies analyst Brian Tanquilut ...
Express Scripts Holding Company (ESRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||72.11 x 400|
|Ask||73.75 x 900|
|Day's Range||71.60 - 72.89|
|52wk Range||65.55 - 89.20|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||17.87|
|Avg Vol (3m)||3,584,754|
|Dividend & Yield||N/A (N/A)|